Background: Short-term follow-up of COVID-19 patients reveals pulmonary dysfunction, myocardial damage and severe psychological distress. Little is known of the burden of these sequelae, and there are no clear recommendations for follow-up of COVID-19 patients. In this multi-disciplinary evaluation, cardiopulmonary function and psychological impairment after hospitalization for COVID-19 are mapped. Methods: We evaluated patients at our outpatient clinic 6 weeks after discharge. Cardiopulmonary function was measured by echocardiography, 24-hours ECG monitoring and pulmonary function testing. Psychological adjustment was measured using questionnaires and semi-structured clinical interviews. A comparison was made between patients admitted to the general ward and Intensive care unit (ICU), and between patients with a high versus low functional status. Findings: Eighty-one patients were included of whom 34 (41%) had been admitted to the ICU. New York Heart Association class II-III was present in 62% of the patients. Left ventricular function was normal in 78% of patients. ICU patients had a lower diffusion capacity (mean difference 12,5% P = 0.01), lower forced expiratory volume in one second and forced vital capacity (mean difference 14.9%; P<0.001; 15.4%; P<0.001; respectively). Risk of depression, anxiety and PTSD were 17%, 5% and 10% respectively and similar for both ICU and non-ICU patients. Interpretation: Overall, most patients suffered from functional limitations. Dyspnea on exertion was most frequently reported, possibly related to decreased DLCOc. This could be caused by pulmonary fibrosis, which should be investigated in long-term follow-up. In addition, mechanical ventilation, deconditioning, or pulmonary embolism may play an important role.
SummaryRadial intercalation is a fundamental process responsible for the thinning of multilayered tissues during large-scale morphogenesis; however, its molecular mechanism has remained elusive. Using amphibian epiboly, the thinning and spreading of the animal hemisphere during gastrulation, here we provide evidence that radial intercalation is driven by chemotaxis of cells toward the external layer of the tissue. This role of chemotaxis in tissue spreading and thinning is unlike its typical role associated with large-distance directional movement of cells. We identify the chemoattractant as the complement component C3a, a factor normally linked with the immune system. The mechanism is explored by computational modeling and tested in vivo, ex vivo, and in vitro. This mechanism is robust against fluctuations of chemoattractant levels and expression patterns and explains expansion during epiboly. This study provides insight into the fundamental process of radial intercalation and could be applied to a wide range of morphogenetic events.
Aims To analyse and optimize the interobserver agreement for gross target volume (GTV) delineation on cardiac computed tomography (CCT) based on electroanatomical mapping (EAM) data acquired to guide radiotherapy for ventricular tachycardia (VT). Methods and results Electroanatomical mapping data were exported and merged with the segmented CCT using manual registration by two observers. A GTV was created by both observers for predefined left ventricular (LV) areas based on preselected endocardial EAM points indicating a two-dimensional (2D) surface area of interest. The influence of (interobserver) registration accuracy and availability of EAM data on the final GTV and 2D surface location within each LV area was evaluated. The median distance between the CCT and EAM after registration was 2.7 mm, 95th percentile 6.2 mm for observer #1 and 3.0 mm, 95th percentile 7.6 mm for observer #2 (P = 0.9). Created GTVs were significantly different (8 vs. 19 mL) with lowest GTV overlap (35%) for lateral wall target areas. Similarly, the highest shift between 2D surfaces was observed for the septal LV (6.4 mm). The optimal surface registration accuracy (2.6 mm) and interobserver agreement (Δ interobserver EAM surface registration 1.3 mm) was achieved if at least three cardiac chambers were mapped, including high-quality endocardial LV EAM. Conclusion Detailed EAM of at least three chambers allows for accurate co-registration of EAM data with CCT and high interobserver agreement to guide radiotherapy of VT. However, the substrate location should be taken in consideration when creating a treatment volume margin.
Key Points Question What is the rate of incidental skin cancer detection in urgent skin cancer clinics, and are incidental cancers more likely to be detected in patients with a clinically suspicious index lesion than in those without? Findings In a cohort study including 4726 patients, 1117 malignant lesions were detected, 22% of which were identified incidentally by total body skin examinations corresponding to an incidental lesion detection rate of 5.1%. Detection of a malignant incidental lesion by total body skin examinations was significantly more likely in patients presenting with an index lesion suspicious for malignancy, compared with patients who presented with index lesions judged to be clinically benign. Meaning The findings of this study suggest that total body skin examinations may be useful for detecting incidental skin cancers and that patients with suspicious index lesions should be prioritized.
Funding Acknowledgements Type of funding sources: Public hospital(s). Main funding source(s): Leiden University Medical Centre Background Substrate identification after myocardial infarction (MI) relies on voltage mapping. Early reperfusion results in non-transmural scar (NTS). Narrow-spaced microelectrodes (ME) are thought to have a limited field of view (FOV). The role of ME for delineation of NTS is unclear. Purpose To evaluate mapping with multi-size electrodes for identifying NTS, validated against high-resolution ex-vivo cardiac magnetic resonance imaging (HR-LGE-CMR). Methods Nine swine with early reperfusion MI underwent endocardial electroanatomical voltage mapping (EAVM) with the QDOT catheter which incorporates three ME in the 3.5mm tip electrode. HR-LGE-CMR (0.3mm slices) were obtained and merged with EAVM. At each EAVM point a transmural cylinder (5mm radius) was projected on the CMR and the volume of viable myocardium (VM) in the cylinder quantified (Otsu method). Unipolar (UV) and bipolar (BV) voltages from conventional (c) and microelectrodes (µ) were related to VM. Cut-off values for normal myocardium were based on 5th percentiles of areas without fibrosis. Results In each swine 220 (IQR 216-260) mapping points were collected (total 2322 points). Cut-off for normal myocardium were 3.18 mV, 0.85 mV, 3.28mV and 1.93 mV for UVc, BVc, UVµ and BVµ, respectively. Wall thickness (WT) was reduced in areas with fibrosis vs. no fibrosis (5.4mm, IQR 3.2- 6.9 vs. 7.4mm, IQR 5.3 - 9.6). All voltages were reduced at sites with fibrosis vs. no fibrosis (UVs 4.4mV vs. 6.8mV; BVc 1.2mV vs. 2.1mV; UVµ 2.5mV vs. 5.5mV, and BVµ 2.9mV vs. 5.4mV, all p<0.001). For areas with any fibrosis, all voltages increased with increasing WT up to the maximal WT of 13mm (fig. 1). Similarly, all voltages increased with an increase in VM volumes from >200mm3 to >600 mm3 (equivalent to a cylinder with h=7.64mm) (fig. 2) with the strongest correlation for UVµ (r=0.47). Below a volume of 200mm3 VM voltages did not correlate significantly with VM. Conclusion In NTS, UVc, BVc, and, notably, BVµ and UVµ increase with increasing WT and increasing transmural volume of VM, with the biggest role perhaps laid out for UVµ to estimate transmural VM. EAVM cannot accurately delineate areas with the lowest amount of VM, potentially due to insufficient far field cancellation in NTS. Both these findings argue against a limited FOV of ME.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.